Invesaro

Stocks Health care OMER

NASDAQ · Health care

Omeros Corp (OMER)

In fiscal 2025 capital spending exceeded operating cash flow by $116.2M. At June 30, 2026 it held $2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.

Free, no password. An email when OMER files with the SEC.

Price
$17.30
-1.43% on the day · November 10, 2026
52-week range $6.24 to $21.24
Market cap
$1.3B

Key facts about Omeros Corp

Net worth
Omeros Corp has a market value (market cap) of $1.3B at the latest share price, and shareholders' equity of -$51.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2020 revenue was $73.8M (-34.0% year on year), with a net loss of $138.1M.
Cash flow
In fiscal 2025 operations used $116.1M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 12, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Omeros Corp's next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Omeros Corp does

Omeros Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker OMER.

Revenue and profit by year

Revenue
FY18: $29.9M $29.9M FY18FY19: $111.8M $111.8M FY19FY20: $73.8M $73.8M FY20
Net income
FY18: -$126.8M -$126.8M FY18FY19: -$84.5M -$84.5M FY19FY20: -$138.1M -$138.1M FY20FY21: $194.2M $194.2M FY21FY22: $47.4M $47.4M FY22FY23: -$117.8M -$117.8M FY23FY24: -$156.8M -$156.8M FY24FY25: -$3.4M -$3.4M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/a-$122.8M-$3.4M-$0.05-$116.2M
2024n/a-$167M-$156.8M-$2.70-$149M
2023n/a-$164.5M-$117.8M-$1.88$74.3M
2022n/a-$163.4M$47.4M$0.76-$86.6M
2021n/a-$173.6M$194.2M$3.12-$110M
2020$73.8M-$156.9M-$138.1M-$2.41-$100.4M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around November 12, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 13, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Latest SEC filings

What Omeros Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 30, 2026
  2. August 13, 2026
  3. August 13, 2026
  4. August 12, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue was $28.5M; diluted EPS $0.15 versus -$0.43.
  5. August 12, 2026
  6. July 29, 2026
  7. July 20, 2026
  8. July 6, 2026
  9. June 25, 2026
  10. June 18, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 30, 2026. Insider transactions on SEC

Insider trades

What the people running Omeros Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $2.2M worth of shares in the last 90 days and bought none on the open market. 32% of the selling was pre-planned under Rule 10b5-1 trading plans.

Bought (open market)
$0
last 90 days
Sold
$2.2M
last 90 days
Net sold
115,906
$2.2M
DateInsiderWhatSharesPriceValueFiling
September 23, 2026 Borges David J.VP, Finance & CAO Exercised options 10,000 $15.58 $155.8K Form 4
September 23, 2026 Borges David J.VP, Finance & CAO Soldpre-planned (10b5-1) 10,000 $20.95 $209.5K Form 4
September 22, 2026 Borges David J.VP, Finance & CAO Exercised options 5,000 $3.93 $19.7K Form 4
September 22, 2026 Borges David J.VP, Finance & CAO Exercised options 5,000 $2.94 $14.7K Form 4
September 22, 2026 Borges David J.VP, Finance & CAO Soldpre-planned (10b5-1) 10,000 $20.95 $209.5K Form 4
August 31, 2026 Cancelmo Peter BVP, General Counsel Exercised options 25,000 $2.94 $73.5K Form 4
August 31, 2026 Cancelmo Peter BVP, General Counsel Sold 25,000 $18.54 $463.5K Form 4
August 28, 2026 Cancelmo Peter BVP, General Counsel Exercised options 25,000 $2.94 $73.5K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns OMER

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

No holder of 5% or more has filed about this company in that window.

Latest filings below 5%: Ingalls & Snyder LLC 4.8% (April 23, 2026); The Vanguard Group 0% (March 27, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

3 insiders reported holding 1,504,575 shares in total, about $26M at the last price.

HolderSharesAs of
Demopulos Gregory A MDChairman, CEO & President, Director 1,469,308 February 18, 2026
Cable Thomas J.Director 35,067 August 20, 2026
Cancelmo Peter BVP, General Counsel 200 August 31, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about OMER

What does Omeros Corp do?

Omeros Corp is a company in the Health care sector, listed on NASDAQ as OMER. Its shares trade on NASDAQ under the ticker OMER.

What is Omeros Corp's net worth?

Omeros Corp has a market value (market cap) of $1.3B at the latest share price, and shareholders' equity of -$51.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Omeros Corp profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $124.8M.

When did Omeros Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the executive or director change from October 30, 2026.

When is Omeros Corp's next earnings report?

Omeros Corp's next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare OMER with

Compare OMER with any company

Follow OMER

Get an email when Omeros Corp files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when OMER files with the SEC.

Where the numbers come from

Financial figures are the values Omeros Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.